Development and evaluation of macrophage targeted multidrug therapy against visceral leishmaniasis
In this study, we fabricated PCL-nanoparticles by encapsulating dual drugs as amphotericin B and doxorubicin via double-emulsion solvent evaporation method also incorporated with ligand-lectin for targeting the infested macrophage cells and prove importance against VL. Different independent processi...
Main Authors: | Prachi sharma, Swati Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Mazandaran University of Medical Sciences
2017-05-01
|
Series: | Pharmaceutical and Biomedical Research |
Subjects: | |
Online Access: | http://pbr.mazums.ac.ir/browse.php?a_code=A-10-100-1&slc_lang=en&sid=1 |
Similar Items
-
PLGA-based macrophage-mediated drug targeting for the treatment of visceral leishmaniasis
by: Swati Gupta, et al.
Published: (2017-05-01) -
THE EFFECT OF FLUCONAZOLE AND AMPHOTERICIN B ON MACROPHAGE FUNCTIONS
by: Glazar Irena, et al.
Published: (2015-12-01) -
Nanomedicine Strategies to Target Tumor-Associated Macrophages
by: Karin Binnemars-Postma, et al.
Published: (2017-05-01) -
Synthesis, characterization, and mechanistic studies of a gold nanoparticle–amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity
by: Kumar P, et al.
Published: (2019-08-01) -
Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation
by: Jing Zhang, et al.
Published: (2018-04-01)